Similarly, both pS6 and pAKT are significantly overexpressed in feline cutaneous squamous cell carcinomas (CSCC), suggesting the mTOR pathway plays a critical role in the pathogenesis of feline CSCC and may represent a potential therapeutic target [56]. Here, TAS2R63P is linked to cutaneous squamous cell carcinoma.